NEVRO CORP

 NVROのチャート


 NVROの企業情報

symbol NVRO
会社名 Nevro Corp (NEVRO CORP)
分野(sector)   
産業(industry)   
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 ネブロ(Nevro Corp)は医療機器の提供者である。同社は慢性疼痛患者の生活の質を改善する製品を提供することに重点を置く。同社は慢性疼痛の治療のための神経調節プラットフォームであるSenza脊髄電気刺激(SCS)システムを開発・商品化する。同社のHF10療法は慢性疼痛の治療のための神経調節溶液を送達するように設計される。HF10療法は患者が異常感覚を伴わずに持続的鎮痛軽減を達成することを可能にし、不快なショッキングまたは激しい感覚を避けることができる。HF10療法は解剖学的リードの配置に依存する。Senzaシステムは2ヘルツ(Hz)から10000 Hzまでの電気インパルスを生成する。  ネブロは、米国の医療機器メ―カ―。慢性疼痛の治療のための神経調節プラットフォ―ムを開発し、商品化。同社の製品「SENZA」システムは、HF10治療を提供する脊髄刺激(SCS)システムである。SENZAは、10kHzの波形刺激を出すHF10治療に加え、2Hzから10kHzの電気刺激が出るように設計。感覚異常を起こさずに痛みを軽減する。  Nevro Corp. engages in the provision of medical devices. The firm focuses on providing products that improve the quality of life of patients suffering from debilitating chronic pain. It develops and commercializes senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company was founded by Konstantinos Alataris in March 2006 and is headquartered in Redwood City, CA.
本社所在地 1800 Bridge Parkway Redwood City CA 94065 USA
代表者氏名 D.Keith Grossman
代表者役職名 President Chief Executive Officer Director
電話番号 +1 650-251-0005
設立年月日 38777
市場名 NYSE(ニューヨーク証券取引所)
ipoyear
従業員数 804人
url www.nevro.com
nasdaq_url
adr_tso
EBITDA (百万ドル) -37.85600
終値(lastsale)
時価総額(marketcap)
時価総額 (百万ドル) 1949.35500
売上高 (百万ドル) 387.28900
企業価値(EV) (百万ドル) 1837.20200
当期純利益 (百万ドル) -49.20500
決算概要 BRIEF: For the fiscal year ended 31 December 2018 Nevro Corp revenues increased 19% to $387.3M. Net loss increased 34% to $49.2M. Revenues reflect United States segment increase of 22% to $321.8M. Higher net loss reflects Selling/General/Admin. Expense - Balanci increase of 19% to $238.5M (expense) Research and Development Expense - Bal increase of 29% to $42.6M (expense).

 NVROのテクニカル分析


 NVROのニュース

   Nevro to Present at Upcoming Conferences  2020/09/01 11:00:00 PR Newswire
REDWOOD CITY, Calif., Sept. 1, 2020 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that D. Keith Grossman, Nevro's Chairman, CEO and President, will present…
   Liberty All-Star® Growth Fund, Inc. July 2020 Monthly Update  2020/08/14 21:41:00 Benzinga
BOSTON , Aug. 14, 2020 /PRNewswire/ -- Below is the July 2020 Monthly Update for the Liberty All-Star Growth Fund, Inc. (NYSE: ASG ) Liberty All-Star Growth Fund, Inc. Ticker: ASG Monthly Update, July, 2020 Investment Approach: Fund Style: All-Cap Growth Fund Strategy: Combines three growth style investment managers, each with a distinct capitalization focus (small-, mid- and large-cap) selected and continuously monitored by the Fund's Investment Advisor. Investment Managers: Weatherbie Capital, LLC Small-Cap Growth Congress Asset Management Company, LLP Mid-Cap Growth Sustainable Growth Advisers, LP Large-Cap Growth Top 20 Holdings at Month-End (31.0% of equity portfolio) 1 Chegg, Inc. 2.3% 2 FirstService Corp. 2.1% 3 Nevro Corp. 1.9% 4 Paylocity Holding Corp. 1.7% 5 Microsoft Corp. 1.7% 6 Visa, Inc. 1.6% 7 Facebook, Inc. 1.6% 8 Amazon.com, Inc. 1.6% 9 Progyny, Inc. 1.5% 10 Casella Waste Systems, Inc. Full story available on Benzinga.com
   Global Nerve Repair and Regeneration Market Outlook 2020: Company Profiles of Key Players Axogen, Baxter, Nevro, Nuvectra, Polyganics and Stryker - ResearchAndMarkets.com  2020/08/10 11:59:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Nerve Repair and Regeneration - Global Market Outlook (2018-2027)" report has been added to ResearchAndMarkets.com's offering. The Global Nerve Repair and Regeneration market accounted for $6.46 billion in 2018 and is expected to reach $21.68 billion by 2027 growing at a CAGR of 14.4% during the forecast period. Some of the key factors propelling the market growth are technological developments for nerve repair and regeneration and an increase in healthcare expense
   Nevro to Present at Canaccord Genuity 40th Annual Virtual Growth Conference  2020/08/07 11:00:00 PR Newswire
REDWOOD CITY, Calif., Aug. 7, 2020 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that D. Keith Grossman, Nevro's Chairman, CEO and President, will present…
   Why Is Nevro (NVRO) Up 7.1% Since Last Earnings Report?  2020/06/04 15:31:31 Zacks Investment Research
Nevro (NVRO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
   Why Is Nevro (NVRO) Up 7.1% Since Last Earnings Report?  2020/06/04 15:31:31 Zacks Investment Research
Nevro (NVRO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
   Nevro Appoints Finance Executive Roderick MacLeod as Chief Financial Officer  2020/06/04 11:00:00 PR Newswire
REDWOOD CITY, Calif., June 4, 2020 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced the appointment of Roderick ("Rod") MacLeod as Chief Financial Officer,…
   Nevro's (NVRO) Senza Omnia SCS System Gets CE Mark Approval  2020/05/18 05:59:00 Zacks Investment Research
Nevro (NVRO) received CE mark approval for the Senza Omnia SCS system, which is likely to boost its international presence.
   Nevro Announces CE Mark Approval of Senza® Omnia™ Spinal Cord Stimulation System to Treat Chronic Pain  2020/05/14 11:00:00 PR Newswire
REDWOOD CITY, Calif., May 14, 2020 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced it has received CE mark approval for the Senza® Omnia™ Spinal Cord…
   Nevro (NVRO) Earnings and Revenues Beat Estimates in Q1  2020/05/07 13:14:00 Zacks Investment Research
Nevro's (NVRO) domestic revenues improved on a year-over-year basis in Q1.

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 NEVRO CORP NVRO )

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)